标题
Nucleo-cytoplasmic transport as a therapeutic target of cancer
作者
关键词
Exportin-1 (XPO1), Chromosome Region Maintenance 1 (CRM1), Nuclear-cytoplasmic transport, Cancer treatment
出版物
Journal of Hematology & Oncology
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2014-12-05
DOI
10.1186/s13045-014-0085-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 994PDCLINICAL ACTIVITY OF THE ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SELINEXOR (KPT-330) IN PATIENTS WITH HEAD & NECK SQUAMOS CELL CARCINOMA (HN-SCC)
- (2017) A. Mahipal et al. ANNALS OF ONCOLOGY
- Abstract 3809: Evaluation of the novel, orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in spontaneous canine cancer: Results of phase I and phase II clinical trials
- (2015) Cheryl A. London et al. CANCER RESEARCH
- Abstract B36: Inhibition of Exportin 1 (XPO1) potently suppresses growth of human neuroblastoma cell lines
- (2015) Edward F. Attiyeh et al. CANCER RESEARCH
- A critical role for the NFkB pathway in multiple myeloma
- (2015) Oncotarget
- Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer
- (2015) Jiankun Gao et al. Oncotarget
- Abstract 5541: Therapeutic targeting of CRM1 in ovarian cancer.
- (2014) Takahito M. Miyake et al. CANCER RESEARCH
- Abstract 5210: KPT-330, a selective small molecule inhibitor of nuclear export, is active in bone and soft tissue sarcoma.
- (2014) Jayasree S. Nair et al. CANCER RESEARCH
- A Code for RanGDP Binding in Ankyrin Repeats Defines a Nuclear Import Pathway
- (2014) Min Lu et al. CELL
- XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
- (2014) Giovanni Gravina et al. Journal of Hematology & Oncology
- CBS9106-Induced CRM1 Degradation Is Mediated by Cullin Ring Ligase Activity and the Neddylation Pathway
- (2014) N. Saito et al. MOLECULAR CANCER THERAPEUTICS
- XPO1 (CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer
- (2014) Y. Cheng et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study
- (2014) Cheryl A. London et al. PLoS One
- Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts
- (2014) Shuai Wang et al. PLoS One
- Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells
- (2014) Jennifer Yang et al. PLoS One
- Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models
- (2014) Giovanni Luca Gravina et al. PROSTATE
- Nucleoporins and nucleocytoplasmic transport in hematologic malignancies
- (2014) Akiko Takeda et al. SEMINARS IN CANCER BIOLOGY
- Atomic basis of CRM1-cargo recognition, release and inhibition
- (2014) Ho Yee Joyce Fung et al. SEMINARS IN CANCER BIOLOGY
- Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
- (2013) P. Alberti et al. ANNALS OF ONCOLOGY
- Redirecting traffic using the XPO1 police
- (2013) S. A. Abraham et al. BLOOD
- Prognostic impact and targeting of CRM1 in acute myeloid leukemia
- (2013) K. Kojima et al. BLOOD
- Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias
- (2013) C. J. Walker et al. BLOOD
- KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia
- (2013) Julia Etchin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Knockdown of CRM1 inhibits the nuclear export of p27Kip1 phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer
- (2013) You Wang et al. CANCER LETTERS
- Valeriana jatamansi Constituent IVHD-valtrate As a Novel Therapeutic Agent to Human Ovarian Cancer: in vitro and in vivo Activities and Mechanisms
- (2013) Xiaoguang Li et al. CURRENT CANCER DRUG TARGETS
- PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer
- (2013) Giovanni Luca Gravina et al. ENDOCRINE-RELATED CANCER
- Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomas
- (2013) A. S. Azmi et al. HAEMATOLOGICA
- Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia
- (2013) J. Serrano-Lopez et al. HAEMATOLOGICA
- Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies
- (2013) R. A. Mesa et al. HAEMATOLOGICA
- Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276
- (2013) J Schmidt et al. LEUKEMIA
- CRM1 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas
- (2013) Fang Zhou et al. MEDICAL ONCOLOGY
- p53 SUMOylation promotes its nuclear export by facilitating its release from the nuclear export receptor CRM1
- (2013) Aleixo Santiago et al. MOLECULAR BIOLOGY OF THE CELL
- CRM1 and BRAF Inhibition Synergize and Induce Tumor Regression in BRAF-Mutant Melanoma
- (2013) R. A. Salas Fragomeni et al. MOLECULAR CANCER THERAPEUTICS
- Prognostic Value of Survivin in Patients with Gastric Cancer: A Systematic Review with Meta-Analysis
- (2013) Jin Long Liu et al. PLoS One
- Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1
- (2013) Qingxiang Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CRM1 Is a Cellular Target of Curcumin: New Insights for the Myriad of Biological Effects of an Ancient Spice
- (2013) Mingshan Niu et al. TRAFFIC
- CRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex Vivo
- (2013) Joel G. Turner et al. Journal of Cancer
- Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
- (2012) R. Lapalombella et al. BLOOD
- Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia
- (2012) P. Ranganathan et al. BLOOD
- Abstract 1841: Selective inhibitors of nuclear export (SINE) activate multiple tumor suppressor pathways and kill prostate cancer cells across multiple genotypesin vitroandin vivo
- (2012) Giovanni Luca Gravina et al. CANCER RESEARCH
- Selective Inhibitors of Nuclear Export Block Pancreatic Cancer Cell Proliferation and Reduce Tumor Growth in Mice
- (2012) Asfar S. Azmi et al. GASTROENTEROLOGY
- The dog as a possible animal model for human non-Hodgkin lymphoma: a review
- (2012) Laura Marconato et al. HEMATOLOGICAL ONCOLOGY
- Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors
- (2012) Ori Kalid et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- CRM1 Blockade by Selective Inhibitors of Nuclear Export Attenuates Kidney Cancer Growth
- (2012) Hiromi Inoue et al. JOURNAL OF UROLOGY
- Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
- (2012) J Etchin et al. LEUKEMIA
- CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity
- (2011) K. Sakakibara et al. BLOOD
- An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro
- (2011) Wei Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The cytotoxic styryl lactone goniothalamin is an inhibitor of nucleocytoplasmic transport
- (2010) Jean-Yves Wach et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- BRCA1 16 years later: nuclear import and export processes
- (2010) Marilyn E. Thompson FEBS Journal
- Anguinomycins and Derivatives: Total Syntheses, Modeling, and Biological Evaluation of the Inhibition of Nucleocytoplasmic Transport
- (2010) Simone Bonazzi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells
- (2010) F Zanella et al. ONCOGENE
- The staging and treatment of multicentric high-grade lymphoma in dogs: A review of recent developments and future prospects
- (2010) Laura Marconato VETERINARY JOURNAL
- Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition
- (2009) J. G. Turner et al. CANCER RESEARCH
- Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivo
- (2009) S. C. Mutka et al. CANCER RESEARCH
- EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS
- (2009) Aiguo Shen et al. NEUROSURGERY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
- (2009) Miguel F. Segura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer
- (2008) Aurelia Noske et al. CANCER
- Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells
- (2008) Kang-Seo Park et al. CANCER LETTERS
- CRM1-Mediated Nuclear Export of Proteins and Drug Resistance in Cancer
- (2008) Joel Turner et al. CURRENT MEDICINAL CHEMISTRY
- The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation
- (2008) Pauline J. van der Watt et al. INTERNATIONAL JOURNAL OF CANCER
- Nucleocytoplasmic Traffic of CPEB1 and Accumulation in Crm1 Nucleolar Bodies
- (2008) Michèle Ernoult-Lange et al. MOLECULAR BIOLOGY OF THE CELL
- FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells
- (2008) A N Cornforth et al. ONCOGENE
- Involvement of FKHRL1 in melanoma cell survival and death
- (2008) C. Hilmi et al. Pigment Cell & Melanoma Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search